Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSME2P1 (Proteasome activator subunit 2 pseudogene 1) is a human pseudogene located on chromosome 8 that is homologous to the functional PSME2 gene, which encodes the beta subunit of the 11S proteasome activator complex (PA28 beta). PSME2P1 itself does **not** encode a functional protein and is classified as a pseudogene. While some pseudogenes may play regulatory roles at the RNA level by acting as microRNA decoys or influencing expression of their parental genes, there is currently no reported evidence of such a function for PSME2P1. Therefore, PSME2P1 is **not considered a receptor, enzyme, transporter, or other classical molecular therapeutic target**, and there are no associated drugs, mechanisms of action, or biomarker information for this pseudogene. If you are seeking information about a functional component of the proteasome, such as the **proteasome activator subunit 2 (PSME2, PA28 beta)**, refer instead to entries for the actual coding gene/protein, not to this pseudogene. **Clarification:** The entry "proteasome activator subunit 2 pseudogene 1" (PSME2P1) is a non-coding pseudogene and **not** a functional gene or protein. It is not a druggable or actionable therapeutic target. If your interest concerns the biologically active PA28 beta subunit, that target is encoded by the PSME2 gene, not by PSME2P1.
Not applicable (no known mechanism, as it does not encode a protein).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome activator subunit 2 pseudogene 1 (PSME2P1).